Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

Submitted by admin on November 19, 2018 - 9:45am

Source:

CP Wire

News Tags:

Rocket Pharmaceuticals

Leukocyte Adhesion Deficiency-I

RP-L201

Headline:

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

snippet:

Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT) (“Rocket”) announced on 11/19/18 the clearance of the Company’s Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for RP-L201.

Search form

You are here

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA